Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age - PubMed (original) (raw)
. 2003 Nov 28;278(48):48120-8.
doi: 10.1074/jbc.M306889200. Epub 2003 Sep 12.
Affiliations
- PMID: 12972409
- DOI: 10.1074/jbc.M306889200
Free article
Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age
Aaron C Pawlyk et al. J Biol Chem. 2003.
Free article
Abstract
Autosomal recessive juvenile parkinsonism is a movement disorder associated with the degeneration of dopaminergic neurons in substantia nigra pars compacta. The loss of functional parkin caused by parkin gene mutations is the most common single cause of juvenile parkinsonism. Parkin has been shown to aid in protecting cells from endoplasmic reticulum and oxidative stressors presumably due to ubiquitin ligase activity of parkin that targets proteins for proteasomal degradation. However, studies on parkin have been impeded because of limited reagents specific for this protein. Here we report the generation and characterization of a panel of parkin-specific monoclonal antibodies. Biochemical analyses indicate that parkin is present only in the high salt-extractable fraction of mouse brain, whereas it is present in both the high salt-extractable and RIPA-resistant, SDS-extractable fraction in young human brain. Parkin is present at decreased levels in the high salt-extractable fraction and at increased levels in the SDS-extractable fraction from aged human brain. This shift in the extractability of parkin upon aging is seen in humans but not in mice, demonstrating species-specific differences in the biochemical characteristics of murine versus human parkin. Finally, by using these highly specific anti-parkin monoclonal antibodies, it was not possible to detect parkin in alpha-synuclein-containing lesions in alpha-synucleinopathies, thereby challenging prior inferences about the role of parkin in movement disorders other than autosomal recessive juvenile parkinsonism.
Similar articles
- Parkin ubiquitinates and promotes the degradation of RanBP2.
Um JW, Min DS, Rhim H, Kim J, Paik SR, Chung KC. Um JW, et al. J Biol Chem. 2006 Feb 10;281(6):3595-603. doi: 10.1074/jbc.M504994200. Epub 2005 Dec 6. J Biol Chem. 2006. PMID: 16332688 - Parkin-positive autosomal recessive juvenile Parkinsonism with alpha-synuclein-positive inclusions.
Sasaki S, Shirata A, Yamane K, Iwata M. Sasaki S, et al. Neurology. 2004 Aug 24;63(4):678-82. doi: 10.1212/01.wnl.0000134657.25904.0b. Neurology. 2004. PMID: 15326242 - Dopamine covalently modifies and functionally inactivates parkin.
LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ. LaVoie MJ, et al. Nat Med. 2005 Nov;11(11):1214-21. doi: 10.1038/nm1314. Epub 2005 Oct 16. Nat Med. 2005. PMID: 16227987 - How does parkin ligate ubiquitin to Parkinson's disease?
Kahle PJ, Haass C. Kahle PJ, et al. EMBO Rep. 2004 Jul;5(7):681-5. doi: 10.1038/sj.embor.7400188. EMBO Rep. 2004. PMID: 15229644 Free PMC article. Review. - The synaptic function of parkin.
Sassone J, Serratto G, Valtorta F, Silani V, Passafaro M, Ciammola A. Sassone J, et al. Brain. 2017 Sep 1;140(9):2265-2272. doi: 10.1093/brain/awx006. Brain. 2017. PMID: 28335015 Review.
Cited by
- Activation of parkin by a molecular glue.
Sauvé V, Stefan E, Croteau N, Goiran T, Fakih R, Bansal N, Hadzipasic A, Fang J, Murugan P, Chen S, Fon EA, Hirst WD, Silvian LF, Trempe JF, Gehring K. Sauvé V, et al. Nat Commun. 2024 Sep 19;15(1):7707. doi: 10.1038/s41467-024-51889-3. Nat Commun. 2024. PMID: 39300082 Free PMC article. - Intracellular delivery of Parkin-RING0-based fragments corrects Parkin-induced mitochondrial dysfunction through interaction with SLP-2.
Zanon A, Guida M, Lavdas AA, Corti C, Castelo Rueda MP, Negro A, Pramstaller PP, Domingues FS, Hicks AA, Pichler I. Zanon A, et al. J Transl Med. 2024 Jan 16;22(1):59. doi: 10.1186/s12967-024-04850-3. J Transl Med. 2024. PMID: 38229174 Free PMC article. - Basal activity of PINK1 and PRKN in cell models and rodent brain.
Watzlawik JO, Fiesel FC, Fiorino G, Bustillos BA, Baninameh Z, Markham BN, Hou X, Hayes CS, Bredenberg JM, Kurchaba NW, Fričová D, Siuda J, Wszolek ZK, Noda S, Sato S, Hattori N, Prasad AA, Kirik D, Fox HS, Stauch KL, Goldberg MS, Springer W. Watzlawik JO, et al. Autophagy. 2024 May;20(5):1147-1158. doi: 10.1080/15548627.2023.2286414. Epub 2023 Dec 2. Autophagy. 2024. PMID: 38041584 Free PMC article. - PARIS undergoes liquid-liquid phase separation and poly(ADP-ribose)-mediated solidification.
Kang H, Park S, Jo A, Mao X, Kumar M, Park CH, Ahn JY, Lee Y, Choi JY, Lee YS, Dawson VL, Dawson TM, Kam TI, Shin JH. Kang H, et al. EMBO Rep. 2023 Nov 6;24(11):e56166. doi: 10.15252/embr.202256166. Epub 2023 Oct 23. EMBO Rep. 2023. PMID: 37870275 - Protein stabilization of ITF2 by NF-κB prevents colitis-associated cancer development.
Lee M, Kim YS, Lim S, Shin SH, Kim I, Kim J, Choi M, Kim JH, Koh SJ, Park JW, Shin HW. Lee M, et al. Nat Commun. 2023 Apr 25;14(1):2363. doi: 10.1038/s41467-023-38080-w. Nat Commun. 2023. PMID: 37185280 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous